ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury

Xie, Zhi-yong; Dong, Wei; Zhang, Li; Wang, Meng-jie; Xiao, Zhen-meng; Zhang, Yu-hua; Shi, Wan-xin; Huang, Ying; Yang, Yan; Li, Cui-li; Fu, Lei; Zhao, Xing-chen; Li, Rui-zhao; Li, Zhi-lian; Chen, Yuan-han; Ye, Zhi-ming; Liu, Shuang-xin; Dong, Zheng; Liang, Xin-ling*广东省人民医院; 南方医科大学
Acta Pharmacologica Sinica2022-8DOI: 10.1038/s41401-021-00833-y
7被引10阅读
引用收藏
分享

摘要

Acute kidney injury (AKI) with maladaptive tubular repair leads to renal fibrosis and progresses to chronic kidney disease (CKD). At present, there is no curative drug to interrupt AKI-to-CKD progression. The nuclear factor of the activated T cell (NFAT) family was initially identified as a transcription factor expressed in most immune cells and involved in the transcription of cytokine genes and other genes critical for the immune response. NFAT2 is also expressed in renal tubular epithelial cells (RTECs) and podocytes and plays an important regulatory role in the kidney. In this study, we investigated the renoprotective effect of 11R-VIVIT, a peptide inhibitor of NFAT, on renal fibrosis in the AKI-to-CKD transition and the underlying mechanisms. We first examined human renal biopsy tissues and found that the expression of NFAT2 was significantly increased in RTECs in patients with severe renal fibrosis. We then established a mouse model of AKI-to-CKD transition using bilateral ischemia-reperfusion injury (Bi-IRI). The mice were treated with 11R-VIVIT (5 mg/kg, i.p.) on Days 1, 3, 10, 17 and 24 after Bi-IRI. We showed that the expression of NFAT2 was markedly increased in RTECs in the AKI-to-CKD transition. 11R-VIVIT administration significantly inhibited the nuclear translocation of NFAT2 in RTECs, decreased the levels of serum creatinine and blood urea nitrogen, and attenuated renal tubulointerstitial fibrosis but had no toxic side effects on the heart and liver. In addition, we showed that 11R-VIVIT administration alleviated RTEC apoptosis after Bi-IRI. Consistently, preapplication of 11R-VIVIT (100 nM) and transfection with NFAT2-targeted siRNA markedly suppressed TGF beta-induced HK-2 cell apoptosis in vitro. In conclusion, 11R-VIVIT administration inhibits IRI-induced NFAT2 activation and prevents AKI-to-CKD progression. Inhibiting NFAT2 may be a promising new therapeutic strategy for preventing renal fibrosis after IR-AKI.

学科与关键词

关键词
acute kidney injurychronic kidney diseaseNFAT211R-VIVITrenal fibrosisapoptosisrenal tubular epithelial cellsHK-2 cells
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Acta Pharmacologica Sinica
发表日期
2022-08
卷期
第 43 卷, 第 8 期
页码
2081-2093
DOI
10.1038/s41401-021-00833-y
语言
ENGLISH
期刊收录
CSCD-C.CAST-P
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81770667]; Scientific Research Project of Guangdong Provincial People's Hospital-Summit plan [KJ012019120, KJ012019433]; Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases [2019B121205005]

作者

  • X

    Xie, Zhi-yong (第一作者)

    guangdong prov peoples hosp · 2 · southern med univ

  • D

    Dong, Wei

    guangdong prov peoples hosp

查看全部 19 位作者收起作者
  • Z

    Zhang, Li

  • W

    Wang, Meng-jie

    guangdong prov peoples hosp

  • X

    Xiao, Zhen-meng

    guangdong prov peoples hosp

  • Z

    Zhang, Yu-hua

    guangdong prov peoples hosp · 2 · southern med univ

  • S

    Shi, Wan-xin

    guangdong prov peoples hosp · 2 · southern med univ

  • H

    Huang, Ying

    guangdong prov peoples hosp · 2 · southern med univ

  • Y

    Yang, Yan

    guangdong prov peoples hosp · 2 · southern med univ

  • L

    Li, Cui-li

    guangdong prov peoples hosp

  • F

    Fu, Lei

    guangdong prov peoples hosp

  • Z

    Zhao, Xing-chen

    guangdong prov peoples hosp

  • L

    Li, Rui-zhao

    guangdong prov peoples hosp

  • L

    Li, Zhi-lian

  • C

    Chen, Yuan-han

    guangdong prov peoples hosp

  • Y

    Ye, Zhi-ming

    guangdong prov peoples hosp

  • L

    Liu, Shuang-xin

    guangdong prov peoples hosp

  • D

    Dong, Zheng

  • L

    Liang, Xin-ling (通讯)

    2 · southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417